Many Female Arthritis Drug Users Face Restrictions After Dobbs

More than half of women ages 15 to 49 who use a common arthritis drug risk losing access under restrictive state abortion laws, according to a new study based on nationwide health-care data.

The analysis, published Saturday in the Arthritis & Rheumatology Journal, found that the largest portion of female methotrexate users of reproductive age reside in states like Kentucky, Florida, and others where abortion is banned or only allowed under limited exceptions.

Methotrexate is FDA-approved to treat joint inflammation and improve mobility among patients with inflammatory arthritis, lupus, psoriasis, and other conditions. Some states consider it abortion-inducing because ...